Targeting lung cancer with clinically relevant EGFR mutations using anti-EGFR RNA aptamer-Reference-Cited by-同舟云学术

Targeting lung cancer with clinically relevant EGFR mutations using anti-EGFR RNA aptamer

Published:2023-12 Issue: Volume:34 Page:102046
ISSN:2162-2531
Container-title:Molecular Therapy - Nucleic Acids
language:en
Short-container-title:Molecular Therapy - Nucleic Acids

Author:

Thomas Brian J.,Guldenpfennig Caitlyn,Guan Yue,Winkler Calvin,Beecher Margaret,Beedy Michaela,Berendzen Ashley F.,Ma Lixin,Daniels Mark A.,Burke Donald H.^ORCID,Porciani David

Publisher

Elsevier BV

Subject

Drug Discovery,Molecular Medicine

Reference105 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Sung;CA A Cancer J. Clin.,2021

2. The biology and management of non-small cell lung cancer;Herbst;Nature,2018

3. Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer;Leonetti;Br. J. Cancer,2019

4. Epidermal Growth Factor Receptor Mutation Frequency in Squamous Cell Carcinoma and Its Diagnostic Performance in Cytological Samples: A Molecular and Immunohistochemical Study;Kumari;World J. Oncol.,2019

5. Emerging functions of the EGFR in cancer;Sigismund;Mol. Oncol.,2018

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biosurfactant Nanomicelles and Peptide Integration: Novel Approaches to Targeted Gene Delivery in Colon Cancer Treatment;Current Medicinal Chemistry;2024-08-22

2. Aptamers: ushering in new hopes in targeted glioblastoma therapy;Journal of Drug Targeting;2024-07-03

3. Multiplexed In Vivo Screening Using Barcoded Aptamer Technology to Identify Oligonucleotide-Based Targeting Reagents;Nucleic Acid Therapeutics;2024-06-01

4. Anti-EGFR aptamer exhibits direct anti-cancer effects in NSCLC cells harboring EGFR L858R mutations;2024-04-02